HIMS Insider Trading Activity and SEC Form 4 Filings
HIMS insider trading summary
Over the past 12 months, insiders at Hims & Hers Health, Inc. (HIMS) reported 42 sales worth $15.7M by 8 insiders and 1 open-market purchase worth $1.2M by 1 insider on SEC Form 4. Net insider selling was $14.5M.
Latest HIMS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 28, 2026 | Soleil Boughton | Chief Legal Officer | Sell | $96K (3,462 @ $27.60) |
| Oct 14, 2026 | Soleil Boughton | Chief Legal Officer | Sell | $101K (3,461 @ $29.06) |
| Oct 1, 2026 | Oluyemi Okupe | Chief Financial Officer | Sell | $59K (2,000 @ $29.70) |
| Sep 30, 2026 | Soleil Boughton | Chief Legal Officer | Sell | $101K (3,461 @ $29.17) |
| Sep 22, 2026 | Oluyemi Okupe | Chief Financial Officer | Sell | $877K (29,277 @ $29.95) |
| Sep 17, 2026 | Oluyemi Okupe | Chief Financial Officer | Sell | $355K (12,313 @ $28.82) |
| Sep 16, 2026 | Soleil Boughton | Chief Legal Officer | Sell | $174K (6,236 @ $27.86) |
| Sep 15, 2026 | Michael Chi | Chief Operating Officer | Sell | $398K (14,027 @ $28.39) |
| Sep 15, 2026 | Mohamed Elshenawy | CTO | Sell | $226K (7,954 @ $28.39) |
| Sep 2, 2026 | Soleil Boughton | Chief Legal Officer | Sell | $98K (3,458 @ $28.33) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.